FI922937A0 - Polyhemoglobin stabiliserad med purinderivat och glutation. - Google Patents

Polyhemoglobin stabiliserad med purinderivat och glutation.

Info

Publication number
FI922937A0
FI922937A0 FI922937A FI922937A FI922937A0 FI 922937 A0 FI922937 A0 FI 922937A0 FI 922937 A FI922937 A FI 922937A FI 922937 A FI922937 A FI 922937A FI 922937 A0 FI922937 A0 FI 922937A0
Authority
FI
Finland
Prior art keywords
purinderivat
polyhemoglobin
glutation
och
med
Prior art date
Application number
FI922937A
Other languages
English (en)
Other versions
FI922937A (fi
FI105256B (fi
Inventor
Mario Feola
Jan S Simoni
Peter C Canizaro
Original Assignee
Univ Texas Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech filed Critical Univ Texas Tech
Publication of FI922937A0 publication Critical patent/FI922937A0/fi
Publication of FI922937A publication Critical patent/FI922937A/fi
Application granted granted Critical
Publication of FI105256B publication Critical patent/FI105256B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
FI922937A 1989-12-29 1992-06-24 Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi FI105256B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45907189A 1989-12-29 1989-12-29
US45907189 1989-12-29
US9007442 1990-12-12
PCT/US1990/007442 WO1991009615A1 (en) 1989-12-29 1990-12-12 Polyhemoglobin stabilized by purine derivatives and glutathione

Publications (3)

Publication Number Publication Date
FI922937A0 true FI922937A0 (fi) 1992-06-24
FI922937A FI922937A (fi) 1992-06-24
FI105256B FI105256B (fi) 2000-07-14

Family

ID=23823294

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922937A FI105256B (fi) 1989-12-29 1992-06-24 Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0507870B1 (fi)
JP (1) JP2954347B2 (fi)
KR (1) KR0168866B1 (fi)
AT (1) ATE136466T1 (fi)
AU (1) AU650439B2 (fi)
CA (1) CA2072081C (fi)
DE (1) DE69026513T2 (fi)
DK (1) DK0507870T3 (fi)
ES (1) ES2086532T3 (fi)
FI (1) FI105256B (fi)
GR (1) GR3019775T3 (fi)
IE (1) IE73248B1 (fi)
NO (1) NO309799B1 (fi)
PT (1) PT96398B (fi)
WO (1) WO1991009615A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650388A (en) * 1989-11-22 1997-07-22 Enzon, Inc. Fractionated polyalkylene oxide-conjugated hemoglobin solutions
AU656763B2 (en) * 1989-12-29 1995-02-16 Texas Tech University Health Sciences Center Improved blood substitute
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
JP5410647B2 (ja) * 1999-07-01 2014-02-05 シスメックス株式会社 グリコヘモグロビン分析装置用の標準物質及びコントロール物質
CN116941603A (zh) * 2023-07-21 2023-10-27 浙江康嘉基因技术有限公司 一种新型醛化鸡红细胞的制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4401652A (en) * 1980-12-31 1983-08-30 Allied Corporation Process for the preparation of stroma-free hemoglobin solutions
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
US4831012A (en) * 1984-03-23 1989-05-16 Baxter International Inc. Purified hemoglobin solutions and method for making same
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants

Also Published As

Publication number Publication date
DE69026513T2 (de) 1996-09-12
JP2954347B2 (ja) 1999-09-27
KR920703087A (ko) 1992-12-17
GR3019775T3 (en) 1996-07-31
AU650439B2 (en) 1994-06-23
PT96398B (pt) 1998-12-31
JPH05504766A (ja) 1993-07-22
DK0507870T3 (da) 1996-06-10
DE69026513D1 (de) 1996-05-15
NO309799B1 (no) 2001-04-02
IE73248B1 (en) 1997-05-21
ATE136466T1 (de) 1996-04-15
PT96398A (pt) 1991-10-31
IE904717A1 (en) 1991-07-17
FI922937A (fi) 1992-06-24
KR0168866B1 (ko) 1999-01-15
CA2072081A1 (en) 1991-06-30
WO1991009615A1 (en) 1991-07-11
AU7142591A (en) 1991-07-24
ES2086532T3 (es) 1996-07-01
NO922551D0 (no) 1992-06-26
EP0507870A1 (en) 1992-10-14
EP0507870A4 (en) 1993-08-11
FI105256B (fi) 2000-07-14
CA2072081C (en) 2002-07-30
EP0507870B1 (en) 1996-04-10
NO922551L (no) 1992-08-28

Similar Documents

Publication Publication Date Title
FI922937A0 (fi) Polyhemoglobin stabiliserad med purinderivat och glutation.
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
KR930023370A (ko) 단백질 씨(c) 유도체
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
FI893750A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista
GR3005040T3 (fi)
GR3006807T3 (fi)
NZ229453A (en) A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
AU626070B2 (en) Anticoagulant peptide alcohols
DE69130483D1 (de) Verbesserter blutersatz
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
FI913909A0 (fi) t-PA pro:n stabilointi
PH27369A (en) Glutaric acid derivatives and preparations thereof
TH14151EX (th) อนุพันธ์ต่าง ๆ ของอิมิดาโซลที่เป็นตัวต่อต้านฤทธิ์แอนจิโอเทนซิน ii, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้บำบัดโรค